Cervical cancer: 19 of the 20 most affected countries in the world are African

For the first time in the history of public health, the end of a cancer is within reach: this is the message of a joint op-ed published on November 16, 2026, by allAfrica, on the eve of World Cervical Cancer Elimination Day, set for November 17. It is signed by WHO Director-General Tedros Adhanom Ghebreyesus, South African Nono Simelela, and Zambian professor Groesbeck Parham, a gynecologic oncologist.
The figures explain why this battle is being fought primarily in Africa. Each year, more than 600,000 women worldwide are diagnosed with cervical cancer, and approximately 280,000 die from it. Of the twenty countries where the disease hits hardest, nineteen are located in the WHO African region. Women living with HIV are at a six times higher risk, the op-ed specifies.
Targets set in 2020, coverage still at 33%
The global strategy adopted in 2020 by WHO member states aims for 90% of girls to be vaccinated against the human papillomavirus (HPV), 70% of women to be screened, and 90% of patients to receive treatment. Six years later, 166 countries have included the anti-HPV vaccine in their national programs, and 96 are applying a single-dose regimen, which is less expensive. Global coverage, however, remains capped at 33%.
What African countries have already changed
In Rwanda, several districts are already reaching the main WHO targets. Kenya is deploying a national plan, has switched to a single dose, and is expanding screening; in Kiambu County, nurse Martha Wanjiru operates a mobile clinic between urban neighborhoods and the highlands. In Sierra Leone, screening is available in all sixteen districts, and thanks to training provided by Zambian colleagues, local gynecologists are now performing surgeries themselves, free of charge: women who previously had to travel abroad are now being treated at home.
The tools have changed: the HPV test is more effective than a Pap smear or visual inspection with acetic acid, women can collect their own samples, and portable thermal ablation devices allow a nurse to treat a precancerous lesion in a few minutes. In Zambia, survivor Karen Nakawala shared her struggle on national airwaves and leads the Teal Sisters network, which has more than 100,000 members.
The price remains an issue. The authors are calling on the industry to provide pricing that allows low- and middle-income countries to scale up. Australia and Sweden are approaching elimination; the nineteen most affected African countries are still waiting for vaccines, tests, and treatments at prices they can afford.
This article was written in French with the help of artificial intelligence from the sources cited below, then translated from French automatically. Read the original.

